(Q50586063)

English

High viral eradication with a daily 12-week natural interferon-beta treatment regimen in chronic hepatitis C patients with low viral load. IFN-beta Research Group

scientific article published in December 2000

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

High viral eradication with a daily 12-week natural interferon-beta treatment regimen in chronic hepatitis C patients with low viral load. IFN-beta Research Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

1 reference

based on heuristic

inferred from title

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

author name string

Y Shiratori

1

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

R Nakata

2

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

N Shimizu

3

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

H Katada

4

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

S Hisamitsu

5

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

E Yasuda

6

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

M Matsumura

7

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

T Narita

8

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

K Kawada

9

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

M Omata

10

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

IFN-beta Research Group

11

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

publication date

1 December 2000

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

45

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

12

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

2414-2421

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical efficacy of intramuscular human interferon-beta vs interferon-alpha 2b for the treatment of chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: A 4-year follow-up of 211 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phosphorylation of nonstructural 5A protein of hepatitis C virus: HCV group-specific hyperphosphorylation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative assays for hepatitis C virus in serum as predictors of the long-term response to interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus. A prospective, double-blind, randomized study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in interferon alpha and beta signaling. Interferon beta selectively induces the interaction of the alpha and betaL subunits of the type I interferon receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Pharmacokinetics of Interferons

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences between interferon-alpha and -beta treatment for patients with chronic hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, randomized trial comparing lymphoblastoid to recombinant interferon alfa 2a as therapy for chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification of chronic hepatitis: diagnosis, grading and staging

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of chronic viral hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/11258568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1005655428563

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/11258568

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50586063&oldid=2253859322"